APTA — Aptahem AB Share Price
0.000.00%
Last trade - 00:00- SEK18.56m
- SEK14.43m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.28 | ||
| Price to Tang. Book | 7.05 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -12.53% | ||
| Return on Equity | -14.34% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Aptahem AB is a manufacturer of biological products. The company was founded in 2014 and is located in Malmo, Sweden.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 5th, 2014
- Public Since
- April 17th, 2015
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- AktieTorget Stock Exchange
- Shares in Issue
- 12,500,750
- Address
- Norra Vallgatan 58, 4 tr, MALMO, 211 22
- Web
- https://aptahem.com/
- Phone
- Auditors
- Magnus Hahnsjo
Upcoming Events for APTA
Similar to APTA
Abera Bioscience AB
AktieTorget Stock Exchange
Bio-Works Technologies AB
AktieTorget Stock Exchange
Carbiotix AB (publ)
AktieTorget Stock Exchange
Chosa Oncology AB
AktieTorget Stock Exchange
Curasight A/S
AktieTorget Stock Exchange
FAQ
What is the Aptahem AB share price?
As of Today at 19:17 UTC, shares in Aptahem AB are trading at SEK1.49. This share price information is delayed by 15 minutes.
How has the Aptahem AB share price performed this year?
Shares in Aptahem AB last closed at SEK1.49 and the price had moved by -47.69% over the past 365 days. In terms of relative price strength the Aptahem AB share price has underperformed the FTSE Global All Cap Index by -49% over the past year.
What are the analyst and broker recommendations for Aptahem AB?
There is no consensus recommendation for this security.
Find out moreWhat is the Aptahem AB dividend yield?
Aptahem AB does not currently pay a dividend.
Does Aptahem AB pay a dividend?
Aptahem AB does not currently pay a dividend.
When does Aptahem AB next pay dividends?
Aptahem AB does not currently pay a dividend.
How do I buy Aptahem AB shares?
To buy shares in Aptahem AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Aptahem AB?
As of the previous close price of SEK1.49, shares in Aptahem AB had a market capitalisation of SEK18.56m.
Where are Aptahem AB shares listed?
Here are the trading details for Aptahem AB:
- Country of listing: Sweden
- Exchange: AKT
- Ticker Symbol: APTA
What kind of share is Aptahem AB?
Based on an overall assessment of its quality, value and momentum Aptahem AB is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Aptahem AB share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Aptahem AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aptahem AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -8.17%.
As of the last closing price of SEK1.49, shares in Aptahem AB were trading -19.98% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Aptahem AB PE Ratio?
The Aptahem AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK1.49.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Aptahem AB?
We do not have data on Aptahem AB's directors